ClinicalTrialsFinder

Advanced Triple-Negative Breast Cancer Clinical Trials in Beijing, Beijing Municipality

1 recruitingBeijing, Beijing Municipality, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Phase II Clinical Trial of PD-L1 in Combination With Vinorelbine + Cyclophosphamide + Capecitabine (VEX) Metronomic Chemotherapy With or Without Radiotherapy for Advanced Triple-negative Breast Cancer.

Advanced Triple-Negative Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences150 enrolled2 locationsNCT06771609